Skip to main content

Select Drug Profiles

FDA Approvals, Gastroenterology

Keytruda Plus Chemotherapy Receives New FDA Approvals for Advanced Biliary Tract Cancer and 2 Forms of Advanced Gastroesophageal Junction Adenocarcinoma

Tibsovo FDA Approved for Patients With Relapsed Myelodysplastic Syndromes and IDH1 Mutation

FDA Approved Loqtorzi, a PD-1 Inhibitor, for the Treatment of Adults With Metastatic or Recurrent Nasopharyngeal Carcinoma

Fruzaqla FDA Approved for Refractory Metastatic Colorectal Cancer

Rozlytrek Now Approved for Pediatric Patients Older Than 1 Month With Solid Tumors and NTRK Gene Fusion and in New Oral Pellet Form

Interview with the Innovators

Patients Are at the Heart of Everything We Do

Jenny Fox, Wendy Interiano, Mark Peters II, PharmD, Shannon Stempkowski

FDA Authorizes Updated COVID-19 Vaccine Formulations for Better Protection Against Current Variants

Original Research, Mental Health

Changes in Antipsychotic Medication Use Among Medicare Patients in a Nursing Home, 2010 to 2015

Michele Berrios, CHFP; Bruce Pyenson, FSA, MAAA; Kyle Pérez, MPH; Heidi C. Waters, MBA, PhD

Bosulif Now FDA Approved for Pediatric Patients With Chronic Myelogenous Leukemia

FDA Approvals, Infectious Diseases

FDA Approved Abrysvo, First RSV Vaccine for Immunizing Pregnant Women, as Prophylaxis Against RSV Infection in Infants

Page 6 of 244
Results 51 - 60 of 2434